カルシウム拮抗薬の世界市場規模調査＆予測：薬物クラス（ジヒドロピリジン、ベンゾチゼピン、フェニルアルキルアミン）、流通チャネル（病院、小売薬局、その他）、地域別分析、2022-2029年

カルシウム拮抗薬は、カルシウムが心臓や動脈の細胞に入り込むのを止めることで血圧を下げる薬の一種です。

心筋の強い収縮は、カルシウムによって引き起こされます。カルシウム拮抗薬は、動脈を弛緩させることで血液の流れを良くし、心臓に必要な量の酸素が行き渡るようにすることで、これを促進します。市場の成長は、心血管疾患の増加や経口薬の需要増といった重要な要因によってもたらされます。

2021年8月にベーリンガーインゲルハイム社が発表したニュースリリースによると、心不全は慢性的な心腎代謝疾患であり、世界で少なくとも6000万人が罹患しているとされています。心不全の有病率の上昇に伴い、新たな治療法の代替が急務となっています。さらに、高血圧率の上昇、病院の増加、政府の取り組みにより、市場は上昇すると予想されています。例えば、米国病院協会は、2021年時点で米国に6,090の病院が存在すると推定しています。2021年8月に世界保健機関（WHO）が更新したデータによると、世界で7億人以上が未治療の高血圧であり、この年の時点で世界で12億8000万人が高血圧であり、過去数十年に比べて急激に増加しているとのことです。しかし、熟練した専門家の不足が、2022年から2029年の予測期間を通じて市場の成長を阻害しています。

カルシウム拮抗薬の世界市場調査において考慮された主要地域は、アジア太平洋、北米、欧州、中南米、世界のその他の地域です。北米は、心血管疾患の有病率上昇により、主要な市場シェアを占めると予想されます。しかし、アジア太平洋地域は、多数のジェネリック医薬品メーカーとヘルスケア施設の発展により、最も急速に成長する地域と予想されます。

本レポートに含まれる主な市場参入企業は以下のとおりです。

• Bausch Health Company Inc.
• Abbvie Inc
• Lupin Pharmaceuticals, Inc
• Arbor Pharmaceuticals LLC
• Alvogen
• Exela Pharma Sciences, LLC
• Covis Pharma BV
• Novartis AG
• GlaxoSmithKline LLC
• Pfizer Inc

本調査の目的は、近年の様々なセグメント＆国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。市場の詳細なセグメントとサブセグメントを以下に説明します。

薬物クラス別

ジヒドロピリジン

ベンゾチゼピン

フェニルアルキルアミン

販売チャネル別

病院

小売薬局

その他

地域別

北米

米国

カナダ

欧州

英国

ドイツ

フランス

スペイン

イタリア

その他欧州

アジア太平洋地域

中国

インド

日本

オーストラリア

韓国

その他アジア太平洋

ラテンアメリカ

ブラジル

メキシコ

世界のその他の地域

目次

第1章 エグゼクティブサマリー

• 市場スナップショット
• 世界・セグメンテーション別市場推定・予測、2019-2029年
  • カルシウム拮抗薬市場：地域別、2019年～2029年
  • カルシウム拮抗薬市場：薬物クラス別、2019年～2029年
  • カルシウム拮抗薬市場：流通チャネル別、2019-2029年
• 主な動向
• 調査手法の紹介
• 調査前提条件

第2章 カルシウム拮抗薬の世界市場：定義と範囲

• 調査の目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 調査対象年
• 通貨換算レート

第3章 カルシウム拮抗薬の世界市場力学

• カルシウム拮抗薬市場のインパクト分析（2019-2029年）
  • 市場促進要因
    • 心血管疾患の増加
    • 経口薬の需要増加
  • 市場の課題
    • 熟練した専門家の不足
  • 市場機会
    • 小売薬局の需要増
    • 臨床研究および政府のイニシアチブの増加

第4章 カルシウム拮抗薬の世界市場：産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • 社会的
  • 技術的
• 投資採用モデル
• アナリストの結論・提言
• トップ投資機会
• 主要成功戦略

第5章 リスク評価：COVID-19のインパクト

• COVID-19が業界に与える全体的な影響の評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 カルシウム拮抗薬の世界市場：薬物クラス別

• 市場スナップショット
• カルシウム拮抗薬の世界市場、薬物クラス別、業績-ポテンシャル分析
• カルシウム拮抗薬の世界市場、薬物クラス別推定・予測2019～2029年
• カルシウム拮抗薬市場、サブセグメント分析
  • ジヒドロピリジン
  • ベンゾチゼピン
  • フェニルアルキルアミン

第7章 カルシウム拮抗薬の世界市場：流通チャネル別

• 市場スナップショット
• カルシウム拮抗薬の世界市場：流通チャネル別、実績-ポテンシャル分析
• カルシウム拮抗薬の世界市場：流通チャネル別推定・予測2019～2029年
• カルシウム拮抗薬の世界市場：サブセグメント分析
  • 病院
  • 小売薬局
  • その他

第8章 カルシウム拮抗薬の世界市場：地域別分析

• カルシウム拮抗薬市場、地域別市場スナップショット
• 北米
  • 米国
    • 薬物クラス別の推定・予測、2019年～2029年
    • 流通チャネル別の推定・予測、2019年～2029年
  • カナダ
• 欧州のカルシウム拮抗薬市場のスナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州地域
• アジア太平洋地域のカルシウム拮抗薬市場のスナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカのカルシウム拮抗薬市場のスナップショット
  • ブラジル
  • メキシコ
• 世界のその他の地域

第9章 競合情報

• トップ市場戦略
• 企業プロファイル
  • Bausch Health Company Inc.
    • 主な情報
    • 概要
    • 財務（データの入手が可能な場合）
    • 製品概要
    • 最近の開発状況
  • Abbvie Inc
  • Lupin Pharmaceuticals, Inc
  • Arbor Pharmaceuticals LLC
  • Alvogen
  • Exela Pharma Sciences, LLC
  • Covis Pharma BV
  • Novartis AG
  • GlaxoSmithKline LLC
  • Pfizer Inc

第10章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1. Global Calcium Channel Blocker Market, report scope
• TABLE 2. Global Calcium Channel Blocker Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Calcium Channel Blocker Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
• TABLE 4. Global Calcium Channel Blocker Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
• TABLE 5. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. U.S. Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. Canada Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 19. Canada Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. UK Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 22. UK Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. Germany Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 25. Germany Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. France Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 28. France Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. Italy Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 31. Italy Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Spain Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 34. Spain Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. RoE Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 37. RoE Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. China Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 40. China Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. India Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 43. India Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. Japan Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 46. Japan Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. South Korea Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 49. South Korea Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. Australia Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 52. Australia Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. Brazil Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 58. Brazil Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Mexico Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 61. Mexico Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. RoLA Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 64. RoLA Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. Row Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 67. Row Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Calcium Channel Blocker Market
• TABLE 70. List of primary sources, used in the study of global Calcium Channel Blocker Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Calcium Channel Blocker Market, research methodology
• FIG 2. Global Calcium Channel Blocker Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Calcium Channel Blocker Market, key trends 2021
• FIG 5. Global Calcium Channel Blocker Market, growth prospects 2022-2029
• FIG 6. Global Calcium Channel Blocker Market, porters 5 force model
• FIG 7. Global Calcium Channel Blocker Market, pest analysis
• FIG 8. Global Calcium Channel Blocker Market, value chain analysis
• FIG 9. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Calcium Channel Blocker Market, regional snapshot 2019 & 2029
• FIG 15. North America Calcium Channel Blocker Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Calcium Channel Blocker Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Calcium Channel Blocker Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Calcium Channel Blocker Market 2019 & 2029 (USD Billion)
• FIG 19. Global Calcium Channel Blocker Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Calcium Channel Blocker Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2022-2029. Calcium channel blockers are a class of drugs that lower blood pressure by stopping calcium from entering heart and artery cells. Stronger cardiac muscle contractions are caused by calcium. Calcium channel blockers facilitate this by allowing blood arteries to relax, which increases the flow of blood and ensures that the heart receives the necessary amount of oxygen. The market growth is driven by significant factors such as increase in cardiovascular diseases and rising demand for Oral Drugs.

Heart failure is a chronic, incapacitating cardio-renal-metabolic condition that affects at least 60 million people globally, according to a news release published by Boehringer Ingelheim GmbH in August 2021. There is an urgent need for novel treatment alternatives as heart failure prevalence rises. Additionally, the market is anticipated to rise due to rising hypertension rates, an increase in hospitals, and government efforts. For instance, the American Hospital Association estimates that there were 6,090 hospitals in the United States as of 2021. According to data updated by the World Health Organization (WHO) in August 2021, more than 700 million people worldwide have untreated hypertension, and as of that year, 1.28 billion people worldwide had hypertension, a sharp increase over the previous few decades. However, lack of skilled professionals' stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Calcium Channel Blocker Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is expected to hold a major market share owing to increasing prevalence rate of cardiovascular diseases. However, Asia Pacific is expected to be the fastest growing region due to large number of generic manufacturer and developing healthcare facilities.

Major market players included in this report are:

Bausch Health Company Inc.

Abbvie Inc

Lupin Pharmaceuticals, Inc

Arbor Pharmaceuticals LLC

Alvogen

Exela Pharma Sciences, LLC

Covis Pharma BV

Novartis AG

GlaxoSmithKline LLC

Pfizer Inc

Recent Developments in the Market:

• The FDA approved Norliqva (amlodipine) oral solution in February 2022 to treatment hypertension in adults and children aged 6 and older, as well as to prevent coronary artery disease.
• The American Food and Drug Administration (FDA) received provisional permission in May 2022 for Zydus Worldwide DMCC's subsidiary to commercialize Selexipag tablets for the treatment of pulmonary arterial hypertension (PAH) in adults.

Global Calcium Channel Blocker Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Drug Class, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

Dihydropyridine

Benzothizepine

Phenylalkylamine

By Distribution Channel:

Hospitals

Retail Pharmacies

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Calcium Channel Blocker Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Calcium Channel Blocker Market, by Drug Class, 2019-2029 (USD Billion)
  • 1.2.3. Calcium Channel Blocker Market, by Distribution Channel, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Calcium Channel Blocker Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Calcium Channel Blocker Market Dynamics

• 3.1. Calcium Channel Blocker Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increase in Cardiovascular Diseases
    • 3.1.1.2. Rising demand for oral drugs
  • 3.1.2. Market Challenges
    • 3.1.2.1. Lack of skilled professionals
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing demand for retail pharmacies
    • 3.1.3.2. Increased clinical studies and government initiatives

Chapter 4. Global Calcium Channel Blocker Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Calcium Channel Blocker Market, by Drug Class

• 6.1. Market Snapshot
• 6.2. Global Calcium Channel Blocker Market by Drug Class, Performance - Potential Analysis
• 6.3. Global Calcium Channel Blocker Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
• 6.4. Calcium Channel Blocker Market, Sub Segment Analysis
  • 6.4.1. Dihydropyridine
  • 6.4.2. Benzothizepine
  • 6.4.3. Phenylalkylamine

Chapter 7. Global Calcium Channel Blocker Market, by Distribution Channel

• 7.1. Market Snapshot
• 7.2. Global Calcium Channel Blocker Market by Distribution Channel, Performance - Potential Analysis
• 7.3. Global Calcium Channel Blocker Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
• 7.4. Calcium Channel Blocker Market, Sub Segment Analysis
  • 7.4.1. Hospitals
  • 7.4.2. Retail Pharmacies
  • 7.4.3. Others

Chapter 8. Global Calcium Channel Blocker Market, Regional Analysis

• 8.1. Calcium Channel Blocker Market, Regional Market Snapshot
• 8.2. North America Calcium Channel Blocker Market
  • 8.2.1. U.S. Calcium Channel Blocker Market
    • 8.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Calcium Channel Blocker Market
• 8.3. Europe Calcium Channel Blocker Market Snapshot
  • 8.3.1. U.K. Calcium Channel Blocker Market
  • 8.3.2. Germany Calcium Channel Blocker Market
  • 8.3.3. France Calcium Channel Blocker Market
  • 8.3.4. Spain Calcium Channel Blocker Market
  • 8.3.5. Italy Calcium Channel Blocker Market
  • 8.3.6. Rest of Europe Calcium Channel Blocker Market
• 8.4. Asia-Pacific Calcium Channel Blocker Market Snapshot
  • 8.4.1. China Calcium Channel Blocker Market
  • 8.4.2. India Calcium Channel Blocker Market
  • 8.4.3. Japan Calcium Channel Blocker Market
  • 8.4.4. Australia Calcium Channel Blocker Market
  • 8.4.5. South Korea Calcium Channel Blocker Market
  • 8.4.6. Rest of Asia Pacific Calcium Channel Blocker Market
• 8.5. Latin America Calcium Channel Blocker Market Snapshot
  • 8.5.1. Brazil Calcium Channel Blocker Market
  • 8.5.2. Mexico Calcium Channel Blocker Market
• 8.6. Rest of The World Calcium Channel Blocker Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Bausch Health Company Inc.
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Abbvie Inc
  • 9.2.3. Lupin Pharmaceuticals, Inc
  • 9.2.4. Arbor Pharmaceuticals LLC
  • 9.2.5. Alvogen
  • 9.2.6. Exela Pharma Sciences, LLC
  • 9.2.7. Covis Pharma BV
  • 9.2.8. Novartis AG
  • 9.2.9. GlaxoSmithKline LLC
  • 9.2.10. Pfizer Inc

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption